oasis 1 trial oral semaglutide 50 mg weight loss results May be Effective Option for Obesity Treatment, According to Study Authors Efficacy and safety of once-daily

The proportion of patients with PCOS who were prescribed semaglutide or tirzepatide increased from 2.4% in 2021 to 17.6% in 2025, representing a 637.5% relative increase

Interfaces 11 , 3560435612 (2019)

They are the direct result of the medication doing exactly what it was designed to do: slowing down your digestion to help you feel full and satisfied

Who Should Choose Tirzepatide: Ideal Candidates: Need maximum weight loss (50+ pounds) Want most effective medication available Can afford $349-$1,069/month depending on option Have BMI 30 (or 27 with comorbidities) Plateaued on semaglutide or other medications No contraindications to GLP-1/GIP agonists Particularly Good For: Significant obesity (BMI 35) Previous weight loss medication failures Those who want best possible results Patients who tolerate GLP-1s well Cost Comparison: Value Analysis: Cost per % Body Weight Lost: Brand-Name Tirzepatide: 22.5% loss at $12,828/year Cost per %: $570 Compounded Tirzepatide (TrimRx): 22.5% loss at $4,188/year Cost per %: $186 Compounded Semaglutide (TrimRx): 14.9% loss at $2,388/year Cost per %: $160 Both compounded options offer excellent value, with semaglutide being slightly more cost-efficient per percentage lost, while tirzepatide produces greater absolute weight loss

Ozempic and Weight Ozempic causes significant weight loss